-
1Academic Journal
Πηγή: Вестник интенсивной терапии, Iss 1 (2025)
Θεματικοί όροι: RC86-88.9, интраоперационная инфузия, Medical emergencies. Critical care. Intensive care. First aid, новорожденные, гипергликемия, гипогликемия, интраоперационный гликемический профиль
Σύνδεσμος πρόσβασης: https://doaj.org/article/7afe37d10fbd44d08368bf355adbacf1
-
2Academic Journal
-
3Academic Journal
-
4Academic Journal
Πηγή: University Therapeutic Journal, Vol 7, Iss 1 (2025)
Θεματικοί όροι: ранняя диагностика, сахарный диабет 1-го типа, диабетический кетоацидоз, Medicine, дети, гипергликемия, клинические симптомы
Σύνδεσμος πρόσβασης: https://doaj.org/article/93bc4bf8fcb547a382985df4ef8c7675
-
5Academic Journal
-
6Academic Journal
-
7
-
8
-
9Academic Journal
Συγγραφείς: Саитмуродович , Илясов Aзиз, Облаяровна , Хасанова Фарогат, Эшмаматовна , Джуманова Наргиза, Тошпулатович , Раззоков Бунёд
Πηγή: World of Medicine : Journal of Biomedical Sciences; Vol. 2 No. 2 (2025): World of Medicine : Journal of Biomedical Sciences; 94-98 ; 2960-9356
Θεματικοί όροι: метаболизм, аорта, гипергликемия, инсулинорезистентность, дислипидемия, эндотелиальная дисфункция, атерогенная дислипидемия
Περιγραφή αρχείου: application/pdf
-
10Academic Journal
Συγγραφείς: Абдуллаева , Дилафруз, Икрамов , Отабек, Шовалиев, И.Х.
Πηγή: Eurasian Journal of Medical and Natural Sciences; Vol. 5 No. 8 (2025): Eurasian Journal of Medical and Natural Sciences; 33-41 ; Евразийский журнал медицинских и естественных наук; Том 5 № 8 (2025): Евразийский журнал медицинских и естественных наук; 33-41 ; Yevrosiyo tibbiyot va tabiiy fanlar jurnali; Jild 5 Nomeri 8 (2025): Евразийский журнал медицинских и естественных наук; 33-41 ; 2181-287X
Θεματικοί όροι: Сахарный диабет, диабетическая ретинопатия, гипергликемия, дислипедемия, Diabetes mellitus, diabetic retinopathy, hyperglycemia, dyslipidemia
Περιγραφή αρχείου: application/pdf
Διαθεσιμότητα: https://in-academy.uz/index.php/EJMNS/article/view/58401
-
11Academic Journal
Συγγραφείς: Негматова Гульзода Шухратовна, Ортиков Шахзод
Πηγή: SCIENTIFIC JOURNAL OF APPLIED AND MEDICAL SCIENCES; Vol. 4 No. 4 (2025): SCIENTIFIC JOURNAL OF APPLIED AND MEDICAL SCIENCES; 78-89 ; НАУЧНЫЙ ЖУРНАЛ ПРИКЛАДНЫХ И МЕДИЦИНСКИХ НАУК; Том 4 № 4 (2025): SCIENTIFIC JOURNAL OF APPLIED AND MEDICAL SCIENCES; 78-89 ; 2181-3469
Θεματικοί όροι: Глюкокортикоиды, гипергликемия, сахарный диабет
Περιγραφή αρχείου: application/pdf
-
12Academic Journal
Συγγραφείς: V. V. Klimontov, K. S. Shishin, R. A. Ivanov, M. P. Ponomarenko, K. A. Zolotareva, S. A. Lashin, В. В. Климонтов, К. С. Шишин, Р. А. Иванов, М. П. Пономаренко, К. А. Золотарева, С. А. Лашин
Συνεισφορές: The sections on evolutionary analysis of genes and SNP analysis were performed using the Bioinformatics Sharing Centre supported by Budget Project No. FWNR-2022-0006. The authors express their sincere gratitude to O.V. Saik (RICEL – branch of ICG SB RAS) for her significant contribution to data collection and valuable advice on the development of the database. We also thank A.M. Mukhin (ICG SB RAS) for technical assistance in creating the web resource.
Πηγή: Vavilov Journal of Genetics and Breeding; Том 28, № 8 (2024); 1008-1017 ; Вавиловский журнал генетики и селекции; Том 28, № 8 (2024); 1008-1017 ; 2500-3259 ; 10.18699/vjgb-24-88
Θεματικοί όροι: однонуклеотидный полиморфизм, protein, diabetes mellitus, hyperglycemia, hypoglycemia, glucose variability, database, phylostratigraphic index, single nucleotide polymorphism, белок, cахарный диабет, гипергликемия, гипогликемия, вариабельность глюкозы, база данных, филостратиграфический индекс
Περιγραφή αρχείου: application/pdf
Relation: https://vavilov.elpub.ru/jour/article/view/4421/1906; Ceriello A., Monnier L., Owens D. Glycaemic variability in diabetes: clinical and therapeutic implications. Lancet Diabetes Endocrinol. 2019;7(3):221-230. doi 10.1016/S2213-8587(18)30136-0; Chung W.K., Erion K., Florez J.C., Hattersley A.T., Hivert M.F., Lee C.G., McCarthy M.I., Nolan J.J., Norris J.M., Pearson E.R., Philipson L., McElvaine A.T., Cefalu W.T., Rich S.S., Franks P.W. Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2020;63(9):1671-1693. doi 10.1007/s00125-020-05181-w; Day I.N. dbSNP in the detail and copy number complexities. Hum. Mutat. 2010;31(1):2-4. doi 10.1002/humu.21149; Dhawan P., Vasishta S., Balakrishnan A., Joshi M.B. Mechanistic insights into glucose induced vascular epigenetic reprogramming in type 2 diabetes. Life Sci. 2022;298:120490. doi 10.1016/j.lfs.2022.120490; Domazet-Lošo T., Tautz D. A phylogenetically based transcriptome age index mirrors ontogenetic divergence patterns. Nature. 2010; 468(7325):815-819. doi 10.1038/nature09632; Filonov S.V., Podkolodnyy N.L., Podkolodnaya O.A., Tverdokhleb N.N., Ponomarenko P.M., Rasskazov D.A., Bogomolov A.G., Ponomarenko M.P. Human_SNP_TATAdb: a database of SNPs that statistically significantly change the affinity of the TATA-binding protein to human gene promoters: genome-wide analysis and use cases. Vavilovskii Zhurnal Genetiki i Selektsii = Vavilov Journal of Genetics and Breeding. 2023;27(7):728-736. doi 10.18699/VJGB-23-85; Hall E., Dekker Nitert M., Volkov P., Malmgren S., Mulder H., Bacos K., Ling C. The effects of high glucose exposure on global gene expression and DNA methylation in human pancreatic islets. Mol. Cell. Endocrinol. 2018;472:57-67. doi 10.1016/j.mce.2017.11.019; Hanefeld M., Frier B.M., Pistrosch F. Hypoglycemia and cardiovascular risk: is there a major link? Diabetes Care. 2016;39(S.2):S205-S209. doi 10.2337/dcS15-3014; International Diabetes Federation. IDF Diabetes Atlas, 10th ed. Brussels, 2021; Ivanisenko V.A., Saik O.V., Ivanisenko N.V., Tiys E.S., Ivanisenko T.V., Demenkov P.S., Kolchanov N.A. ANDSystem: an Associative Network Discovery System for automated literature mining in the field of biology. BMC Syst. Biol. 2015;9(S2):S2. doi 10.1186/1752-0509-9-S2-S2; Ivanisenko V.A., Demenkov P.S., Ivanisenko T.V., Mishchenko E.L., Saik O.V. A new version of the ANDSystem tool for automatic extraction of knowledge from scientific publications with expanded functionality for reconstruction of associative gene networks by considering tissue-specific gene expression. BMC Bioinformatics. 2019;20(1):34. doi 10.1186/s12859-018-2567-6; Kanehisa M., Sato Y., Kawashima M., Furumichi M., Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2016;44(D1):D457-D462. doi 10.1093/nar/gkv1070; Klimontov V.V., Berikov V.B., Saik O.V. Artificial intelligence in diabetology. Sakharnyi Diabet = Diabetes Mellitus. 2021a;24(2):156-166. doi 10.14341/DM12665 (in Russian); Klimontov V.V., Saik O.V., Korbut A.I. Glucose variability: How does it work? Int. J. Mol. Sci. 2021b;22(15):7783. doi 10.3390/ijms22157783; Kolchanov N.A., Ignatieva E.V., Podkolodnaya O.A., Likhoshvai V.A., Matushkin Yu.G. Gene networks. Vavilovskii Zhurnal Genetiki i Selektsii = Vavilov Journal of Genetics and Breeding. 2013;17(4/2): 833-850 (in Russian); Landrum M.J., Lee J.M., Riley G.R., Jang W., Rubinstein W.S., Church D.M., Maglott D.R. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42:D980-D985. doi 10.1093/nar/gkt1113; Langenberg C., Lotta L.A. Genomic insights into the causes of type 2 diabetes. Lancet. 2018;391(10138):2463-2474. doi 10.1016/S0140-6736(18)31132-2; Li Y., Liang R., Sun M., Li Z., Sheng H., Wang J., Xu P., Liu S., Yang W., Lu B., Zhang S., Shan C. AMPK-dependent phosphorylation of HDAC8 triggers PGM1 expression to promote lung cancer cell survival under glucose starvation. Cancer Lett. 2020;478:82-92. doi 10.1016/j.canlet.2020.03.007; Lyssenko V., Vaag A. Genetics of diabetes-associated microvascular complications. Diabetologia. 2023;66(9):1601-1613. doi 10.1007/s00125-023-05964-x; Maloof A.C., Porter S.M., Moore J.L., Dudás F.Ö., Bowring S.A., Higgins J.A., Fike D.A., Eddy M.P. The earliest Cambrian record of animals and ocean geochemical change. Geol. Soc. Am. Bull. 2010; 122(11-12):1731-1774. doi 10.1130/B30346.1; Mustafin Z.S., Lashin S.A., Matushkin Yu.G. Phylostratigraphic analysis of gene networks of human diseases. Vavilovskii Zhurnal Genetiki i Selektsii = Vavilov Journal of Genetics and Breeding. 2021; 25(1):46-56. doi 10.18699/VJ21.006; Nielsen J. Systems biology of metabolism: A driver for developing personalized and precision medicine. Cell Metab. 2017:25(3):572-579. doi 10.1016/j.cmet.2017.02.002; Orlov Y.L., Anashkina A.A., Klimontov V.V., Baranova A.V. Medical genetics, genomics and bioinformatics aid in understanding molecular mechanisms of human diseases. Int. J. Mol. Sci. 2021;22(18): 9962. doi 10.3390/ijms22189962; Putra S.E.D., Martriano Humardani F., Antonius Y., Jonathan J., Thalia Mulyanata L. Epigenetics of Diabetes: A bioinformatic approach. Clin. Chim. Acta. 2024;557:117856. doi 10.1016/j.cca.2024.117856; Rehni A.K., Dave K.R. Impact of hypoglycemia on brain metabolism during diabetes. Mol. Neurobiol. 2018;55(12):9075-9088. doi 10.1007/s12035-018-1044-6; Saik O.V., Klimontov V.V. Bioinformatic reconstruction and analysis of gene networks related to glucose variability in diabetes and its complications. Int. J. Mol. Sci. 2020;21(22):8691. doi 10.3390/ijms21228691; Saik O.V., Klimontov V.V. Hypoglycemia, vascular disease and cognitive dysfunction in diabetes: insights from text mining-based reconstruction and bioinformatics analysis of the gene networks. Int. J. Mol. Sci. 2021;22(22):12419. doi 10.3390/ijms22222212419; Saik O.V., Klimontov V.V. Gene networks of hyperglycemia, diabetic complications, and human proteins targeted by SARS-CoV-2: what is the molecular basis for comorbidity? Int. J. Mol. Sci. 2022;23:7247. doi 10.3390/ijms23137247; Sasaki T., Kuroko M., Sekine S., Matsui S., Kikuchi O., Susanti V.Y., Kobayashi M., Tanaka Y., Yuasa T., Kitamura T. Overexpression of insulin receptor partially improves obese and diabetic phenotypes in db/db mice. Endocr. J. 2015;62(9):787-796. doi 10.1507/endocrj.ej15-0255; Shojima N., Yamauchi T. Progress in genetics of type 2 diabetes and diabetic complications. J. Diabetes Investig. 2023;14(4):503-515. doi 10.1111/jdi.13970; Vaulont S., Vasseur-Cognet M., Kahn A. Glucose regulation of gene transcription. J. Biol. Chem. 2000;275(41):31555-31558. doi 10.1074/jbc.R000016200; Vega M.E., Finlay J., Vasishtha M., Schwarzbauer J.E. Elevated glucose alters global gene expression and tenascin-C alternative splicing in mesangial cells. Matrix Biol. Plus. 2020;8:100048. doi 10.1016/j.mbplus.2020.100048; Yang Z. PAML 4: Phylogenetic analysis by maximum likelihood. Mol. Biol. Evol. 2007;24(8):1586-1591. doi 10.1093/molbev/msm088; Wilmot E.G., Choudhary P., Leelarathna L., Baxter M. Glycaemic variability: The under-recognized therapeutic target in type 1 diabetes care. Diabetes Obes. Metab. 2019;21(12):2599-2608. doi 10.1111/dom.13842; Zhang S., Ke Z., Yang C., Zhou P., Jiang H., Chen L., Li Y., Li Q. High glucose causes distinct expression patterns of primary human skin cells by RNA sequencing. Front. Endocrinol. 2021;12:603645. doi 10.3389/fendo.2021.603645; Zhang Q., Xiao X., Zheng J., Li M., Yu M., Ping F., Wang T., Wang X. DNA methylation regulates pancreatic gene expression and links maternal high-fat diet to the offspring glucose metabolism. J. Nutr. Biochem. 2024;123:109490. doi 10.1016/j.jnutbio.2023.109490; https://vavilov.elpub.ru/jour/article/view/4421
-
13Academic Journal
Συγγραφείς: D. A. Filonenko, R. V. Orlova, M. I. Gluzman, A. A. Vakhitova, A. Yu. Goryainova, K. S. Grechukhina, I. I. Bykonya, L. G. Zhukova, Д. А. Филоненко, Р. В. Орлова, М. И. Глузман, А. A. Вахитова, А. Ю. Горяинова, К. С. Гречухина, И. И. Быконя, Л. Г. Жукова
Πηγή: Siberian journal of oncology; Том 23, № 6 (2024); 107-117 ; Сибирский онкологический журнал; Том 23, № 6 (2024); 107-117 ; 2312-3168 ; 1814-4861
Θεματικοί όροι: рак молочной железы, hyperglycemia, metformin, breast cancer, гипергликемия, метформин
Περιγραφή αρχείου: application/pdf
Relation: https://www.siboncoj.ru/jour/article/view/3353/1297; Howlader N., Altekruse S.F., Li C.I., Chen V.W., Clarke C.A., Ries L.A., Cronin K.A. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst. 2014; 106(5). doi:10.1093/jnci/dju055.; Mollon L., Aguilar A., Anderson E., Dean J., Davis L., Warholak T., Aizer A.A., Platt E., Bardiya A., Tang D. A systematic literature review of the prevalence of PIK3CA mutations and mutation hotspots in HR+/HER2- metastatic breast cancer. Cancer Res. 2018; 78(s13): 1207.; Соколова Т.Н., Алексахина С.Н., Янус Г.А., Султанбаев А.В., Меньшиков К.В., Лысенко А.Н., Зуков Р.А., Зюзюкина А.В., Мурунова Ю.Н., Россоха Е.И., Бахарев С.Ю., Басова Е.А., Касмынина Т.А., Шумская И.С., Бакшун Я.И., Мусаева Х.С., Хасанова А.И., Дмитриев В.Н., Болиева М.Б., Гадзаова К.Х., Петренко О.Л., Максимов Д.А., Владимиров В.И., Гольдберг В.Е., Попова Н.О., Кибишева М.В., Хамгоков З.М., Васильев А.Е., Иевлева А.Г., Имянитов Е.Н. Частота и спектр мутаций PIK3CA при гормонозависимом HER2-отрицательном распространенном раке молочной железы у российских пациенток. Современная онкология. 2021; 23(1): 61–67. doi:10.26442/18151434.2021.1.; André F., Ciruelos E., Rubovszky G., Campone M., Loibl S., Rugo H.S., Iwata H., Conte P., Mayer I.A., Kaufman B., Yamashita T., Lu Y.S., Inoue K., Takahashi M., Pápai Z., Longin A.S., Mills D., Wilke C., Hirawat S., Juric D.; SOLAR-1 Study Group. Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer. N Engl J Med. 2019; 380(20): 1929–40. doi:10.1056/NEJMoa1813904.; André F., Ciruelos E.M., Juric D., Loibl S., Campone M., Mayer I.A., Rubovszky G., Yamashita T., Kaufman B., Lu Y.S., Inoue K., Pápai Z., Takahashi M., Ghaznawi F., Mills D., Kaper M., Miller M., Conte P.F., Iwata H., Rugo H.S. Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1. Ann Oncol. 2021; 32(2): 208–17. doi:10.1016/j.annonc.2020.11.011.; Rugo H.S., Lerebours F., Ciruelos E., Drullinsky P., Ruiz-Borrego M., Neven P., Park Y.H., Prat A., Bachelot T., Juric D., Turner N., Sophos N., Zarate J.P., Arce C., Shen Y.M., Turner S., Kanakamedala H., Hsu W.C., Chia S. Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study. Lancet Oncol. 2021; 22(4): 489–98. doi:10.1016/S1470-2045(21)00034-6. Erratum in: Lancet Oncol. 2021; 22(5). doi:10.1016/S1470-2045-(21)00194-7.; Инструкция по применению лекарственного препарата. Пикрэй (алпелисиб). Министерство здравоохранения Российской Федерации. [Internet]. URL: https://cdn.pharm-portal.ru/69jxs7cjr4n4gdc2acy5y4x8/instructions/%D0%9B%D0%9F-006279/InstrImg_2020_9_3_1460585/%D0%9B%D0%9F-006279[2020]_0.pdf. [cited 2024 Dec 05].; Rugo H.S., André F., Yamashita T., Cerda H., Toledano I., Stemmer S.M., Jurado J.C., Juric D., Mayer I., Ciruelos E.M., Iwata H., Conte P., Campone M., Wilke C., Mills D., Lteif A., Miller M., Gaudenzi F., Loibl S. Time course and management of key adverse events during the randomized phase III SOLAR-1 study of PI3K inhibitor alpelisib plus fulvestrant in patients with HR-positive advanced breast cancer. Ann Oncol. 2020; 31(8): 1001–10. doi:10.1016/j.annonc.2020.05.001.; Мазурина Н.В., Артамонова Е.В., Белоярцева М.Ф., Волкова Е.И., Ганьшина И.П., Трошина Е.А., Тюляндин С.А., Чубенко В.А. Консенсус по профилактике и коррекции гипергликемии у пациентов, получающих терапию препаратом алпелисиб. Современная онкология. 2020; 22(4): 56–59. doi:10.26442/18151434.2020.4.200566.; Филоненко Д.А., Ибрагимова Т.М., Польшина Н.И., Белогурова А.В., Хатькова Е.И., Арутюнян Э.А., Волкова Е.И., Жукова Л.Г. Таргетная терапия люминального HER2-негативного метастатического рака молочной железы c мутацией PIK3CA: комбинация алпелисиба с фулвестрантом в реальной клинической практике. Медицинский совет. 2021; (20): 75–82. doi:10.21518/2079-701X-2021-20-75-82.; Filonenko D., Zhukova L. Prophylactic use of metformin in patients on alpelisib treatment. J Clin Oncol. 2022; 40(s16). doi:10.1200/JCO.2022.40.16_suppl.e13040.; Шливко И.Л., Гаранина О.Е., Артамонова Е.В., Ганьшина И.П., Жукова Л.Г., Королева И.А., Миченко А.В., Семиглазова Т.Ю., Филоненко Д.А. Консенсус по профилактике и коррекции сыпи у пациентов, получающих терапию препаратом алпелисиб. Современная онкология 2021; 23(4): 572–76. doi:10.26442/18151434.2021.4.201275.; Chia S., Neven P., Ciruelos E.M., Lerebours F., Ruiz-Borrego M., Drullinsky P., Prat A., Park Y.H., Juric D., Turner N.C., Chattar Y., Patino H., Akdere M., Rugo H. Alpelisib + endocrine therapy in patients with PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Analysis of all 3 cohorts of the BYLieve study. J Clin Oncol. 2023; 41(s16). doi:10.1200/JCO.2023.41.16_suppl.1078.; Borrego M.R., Tolosa P., Blanch S., Fernández A., Urriticoechea A., Blancas I., Saura C., Rojas B., Bermejo B., Ponce J., Gión M., Llabres E., Galve E., Cueva J.F., López A., Alonso-Romero J.L., González-Santiago S., De Dueñas E.M., Peralta F.G., Ciruelos E., Pérez-García J.M., Llombart-Cussac A., Cortés J. Metformin (MET) for the prevention of alpelisib (ALP)-related hyperglycemia (HG) in PIK3CA-mutated, hormone receptor-positive (HR[+]) HER2-negative (HER2[-]) advanced breast cancer (ABC): The METALLICA study. SABCS. 2023; 83(5s). doi:10.1158/1538-7445.SABCS22-PD8-02.; Rugo H., Gennari A., Chia S., Juric D., Vasan N., Küemmel Sh., Neven P., Lerebours F., Ruíz-Borrego M., Razavi P., Singh J., Chattar Y., Akdere M., Ciruelos E. Effect of Alpelisib Dose Modification for AE Management on Progression-Free Survival and Treatment Duration in SOLAR-1 and BYLieve Clinical Trials. SABCS. 2023.; Chia S., Ruiz-Borrego M., Drullinsky P., Juric D., Bachelot T., Rugo H.S., Ciruelos E., Lerebours F., Prat A., Akdere M., Arce C., Gu E., Turner N.C. Impact of Duration of Prior Cyclin-Dependent Kinase 4/6 Inhibitor Therapy on Alpelisib Benefit in Patients With Hormone Receptor-Positive (HR+), Human Epidermal Growth Factor Receptor-2-Negative (HER2-), PIK3CA-Mutated Advanced Breast Cancer (ABC) From BYLieve. ASCO. 2021; 39(s15). https://doi.org/10.1200/JCO.2021.39.15_sup-pl.1060.; https://www.siboncoj.ru/jour/article/view/3353
-
14Academic Journal
Συγγραφείς: Loghin-Oprea, N., Șalaru, V.A., Stratulat, S.P., Mazur-Nicorici, L.M., Mazur, M.V.
Πηγή: Sănătate Publică, Economie şi Management în Medicină 102 (5) 39-45
Θεματικοί όροι: maladii reumatice, сахарный диабет, glucocorticoizi, diabetes, глюкокортикоиды, ревматические заболевания, diabet zaharat, hiperglicemie, rheumatic diseases, glucocorticosteroids, hyperglycemia, гипергликемия
Περιγραφή αρχείου: application/pdf
Σύνδεσμος πρόσβασης: https://ibn.idsi.md/vizualizare_articol/215757
-
15Academic Journal
Συγγραφείς: Журакулова Зебунисо Ахтамовна
Πηγή: SCIENTIFIC JOURNAL OF APPLIED AND MEDICAL SCIENCES; Vol. 3 No. 5 (2024): AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI; 782-785 ; НАУЧНЫЙ ЖУРНАЛ ПРИКЛАДНЫХ И МЕДИЦИНСКИХ НАУК; Том 3 № 5 (2024): AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI; 782-785 ; 2181-3469
Θεματικοί όροι: сахарный диабет, гипергликемия, дисфункция эндотелия, сердечно-сосудистые заболевания
Περιγραφή αρχείου: application/pdf
-
16Academic Journal
Συγγραφείς: Ражабова Г.Х., Джумаев К.Ш.
Πηγή: SCIENTIFIC JOURNAL OF APPLIED AND MEDICAL SCIENCES; Vol. 3 No. 5 (2024): AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI; 304-310 ; НАУЧНЫЙ ЖУРНАЛ ПРИКЛАДНЫХ И МЕДИЦИНСКИХ НАУК; Том 3 № 5 (2024): AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI; 304-310 ; 2181-3469
Θεματικοί όροι: метаболический синдром, этнические особенности, абдоминальное ожирение, артериальная гипертензия, дислипидемия, гипергликемия
Περιγραφή αρχείου: application/pdf
-
17Academic Journal
Συγγραφείς: Зарипович, Хамдамов Бахтияр, Шарифович, Рахимов Абдурасул
Πηγή: SCIENTIFIC JOURNAL OF APPLIED AND MEDICAL SCIENCES; Vol. 3 No. 4 (2024): AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI; 132-136 ; НАУЧНЫЙ ЖУРНАЛ ПРИКЛАДНЫХ И МЕДИЦИНСКИХ НАУК; Том 3 № 4 (2024): AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI; 132-136 ; 2181-3469
Θεματικοί όροι: Сахарный диабет, диабетическая ретинопатия, полинейроангиопатия, нефропатия, гипергликемия, атеросклероз
Περιγραφή αρχείου: application/pdf
-
18Academic Journal
Συγγραφείς: Авлаевич, Рузиев Ойбек
Πηγή: SCIENTIFIC JOURNAL OF APPLIED AND MEDICAL SCIENCES; Vol. 3 No. 12 (2024): AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI; 341-343 ; НАУЧНЫЙ ЖУРНАЛ ПРИКЛАДНЫХ И МЕДИЦИНСКИХ НАУК; Том 3 № 12 (2024): AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI; 341-343 ; 2181-3469
Θεματικοί όροι: сахарный диабет, дети, состав тела, биоимпеданс, морфометрия, мышечная масса, жир, гипергликемия, диабетический контроль
Περιγραφή αρχείου: application/pdf
-
19Academic Journal
Συγγραφείς: Yu. A. Manuylova, E. P. Pavlicova, A. V. Potapenko, M. A. Truhanova, A. G. Klementyeva, Ю. А. Мануйлова, Е. П. Павликова, А. В. Потапенко, М. A. Труханова, А. Г. Клементьева
Πηγή: Translational Medicine; Том 11, № 2 (2024); 191-200 ; Трансляционная медицина; Том 11, № 2 (2024); 191-200 ; 2410-5155 ; 2311-4495
Θεματικοί όροι: стрессорная гипергликемия, insulin therapy, intraoperative glucose, stress hyperglycemia, интраоперационная глюкоза, отрезная точка для глюкозы
Περιγραφή αρχείου: application/pdf
Relation: https://transmed.almazovcentre.ru/jour/article/view/882/567; https://transmed.almazovcentre.ru/jour/article/downloadSuppFile/882/1964; https://transmed.almazovcentre.ru/jour/article/downloadSuppFile/882/1965; Тарасова И.А., Шестакова А.Л., Никола В.В. Инсулинорезистентность после хирургических вмешательств. Сахарный диабет. 2017; 20(2): 119–125. https://doi.org/10.14341/7637; Garg R, Grover A, McGurk S, Rawn JD. Predictors of hyperglycemia after cardiac surgery in nondiabetic patients. Thorac Cardiovasc Surg. 2013; 145(4): 1038–7.; Khetarpal R, Chatrath V, Kaur J, et al. Impact of different intravenous fluids on blood glucose levels in nondiabetic patients undergoing elective major noncardiac surgeries. Anesth Essays Res. 2016; 10(3): 425–431. DOI:10.4103/0259-1162.176411.; Lazzeri C, Valente S, Chiostri M, et al. The glucose dysmetabolism in the acute phase of non-diabetic ST-elevation myocardial infarction: from insulin resistance to hyperglycemia. Acta Diabetol. 2003; 50(3): 293–300. DOI:10.1007/s00592-011-0325-6.; Ishihara M, Kojima S, Sacamoto T, et al. Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J. 2005; 150(4): 814–22. DOI:10.1016/j.ahj.2004.12.020.; Weston C, Walker L, Birkhead J. Early impact of insulin treatment on mortality for hyperglycaemic patients without known diabetes who present with an acute coronary syndrome. Heart. 2007; 93(12): 1542–1546. DOI:10.1136/hrt.2006.108696.; Lazzeri C, Valente S, Chiostri M, et al. In-hospital peak glycemia and prognosis in STEMI patients without earlier known diabetes. Eur J Cardiovasc Prev Rehabil. 2010; 17(4): 419–23. DOI:10.1097/HJR.0b013e328335f26f.; Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrin Metab. 2002; 87:978–82. DOI:10.1210/jcem.87.3.8341.; Shanks AM, Woodrum DT, Kumar SS, et al. Intraoperative hyperglycemia is independently associated with infectious complications after non-cardiac surgery. Anesthesiol. 2018 Jul 19;18(1):90. DOI:10.1186/s12871-018-0546-0.; Xiong X, Chen D, Cai S, et al. Association of intraoperative hyperglycemia with postoperative composite infection after cardiac surgery with cardiopulmonary bypass: A retrospective cohort study. Front Cardiovasc Med. 2023; Jan 13:9:1060283. DOI:10.3389/fcvm.2022.1060283.; Shah NJ , Leis A , Kheterpal S , et al. Association of intraoperative hyperglycemia and postoperative outcomes in patients undergoing non-cardiac surgery: a multicenter retrospective study. BMC Anesthesiol. 2020; May 7;20(1):106. DOI:10.1186/s12871-020-01022-w.; Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006; 55: 3151–59. DOI:10.2337/db06-0855.; Ishihara M, Inoue I, Kawagoe T, et al. Is admission hyperglycaemia in non-diabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance? Eur Heart J. 2006; 27: 2413–19. DOI:10.1093/eurheartj/ehl271.; Cao JJ, Hudson M, Jankowski M, et al. Relation of chronic and acute myocardial infarction with diabetes mellitus. Am J Cardiol. 2005; 96: 183–86. DOI:10.1016/j.amjcard.2005.03.040.; Fogelholm R, Murros K, Rissanen A, et al. Admission blood glucose and short term survival in primary intracerebral haemorrhage: a population based study. J Neurol Neurosurg Psychiatry. 2005; 76: 349–53. DOI:10.1136/jnnp.2003.034819.; Nair BG, Neradilek MB, Newman S-F, et al. Association between acute phase perioperative glucose parameters and postoperative outcomes in diabetic and non-diabetic patients undergoing non-cardiac surgery. Am J Surg. 2019; Aug;218(2):302–310. DOI:10.1016/j.amjsurg.2018.10.024.; Krinsley JS. Glycemic control, diabetic status, and mortality in heterogeneous population of critically ill patients before and during the era of intensive glycemic management: six and one-half years experience at a university-affiliated community hospital. Semin Thorac Cardiovasc Surg. 2006; 18: 317–25. DOI:10.1053/j.semtcvs.2006.12.003.; Reudink M, Huisman DE, van Rooijen SJ. Association Between Intraoperative Blood Glucose and Anastomotic Leakage in Colorectal Surgery. J Gastrointest Surg. 2021; Oct;25(10):2619–2627. DOI:10.1007/s11605-021-04933-2.; Shi Z, Tang S, Chen Y, et al. Application of glycaemic control optimization programme in patients with stress hyperglycaemia. Nurs Crit Care. 2016; 21 (5): 304– 10. DOI:10.1111/nicc.12121.; Nygren J, Thorell A, Ljungqvist O. Preoperative oral carbohydrate nutrition: an update. Curr Opin Clin Nutr Metab Care. 2001; 4 (4): 255–9. DOI:10.1097/00075197-200107000-00002.; Soop M, Nygren J, Thorell A, et al. Stress-induced insulin resistance: recent developments. Curr Opin Clin Nutr Metab Care. 2007; 10 (2): 181–6. DOI:10.1097/MCO.0b013e32801481df.; Kiran RP, Turina M, Hammel J, et al. The clinical significance of an elevated postoperative glucose value in non-diabetic patients after colorectal surgery: evidence for the need for tight glucose control? Ann Surg. 2013; 258: 599–604. DOI:10.1097/SLA.0b013e3182a501e3.; Kwon S, Thompson S, Dellinger P, et al. Importance of perioperative glycemic control in general surgery: a report from the surgical care and outcomes assessment program. Ann Surg. 2013; 257: 8–14. DOI:10.1097/SLA.0b013e31827b6bbc.; Fiorillo C, Rosa F, Quero G, et al. Postoperative hyperglycemia in nondiabetic patients after gastric surgery for cancer: perioperative outcomes. Gastric cancer. 2017; 20 (3): 536–542. DOI:10.1007/s10120-016-0621-5.; McAlister F, Man J, Bistritz L, et al. Diabetes and coronary artery bypass surgery: an examination of perioperative glycemic control and outcomes. Diabetes Care. 2003; 26: 1518–24. DOI:10.2337/diacare.26.5.1518.; Latham R, Lancaster A, Covington J, et al. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol. 2001; 22: 607–12. DOI:10.1086/501830.; Garazi E, Bridge S, Caffarelli A, et al. Acute cellular insulin resistance and hyperglycemia associated with hypophosphatemia after cardiac surgery. AA Case Rep. 2015; 4(2): 22–5. DOI:10.1213/XAA.0000000000000112.; Gandhi G, Nuttall G, Abel M, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc. 2005; 80 (7): 862–6. DOI:10.4065/80.7.862.; Windmann V, Spies C, Knaak C, et al. Intraoperative hyperglycemia increases the incidence of postoperative delirium. Minerva Anestesiol 2019 Nov; 85(11):1201–1210. DOI:10.23736/S0375-9393.19.13748-0.; Shuford R, Miller-Ocuin JL. Hyperglycemia in the Perioperative Period. Clin Colon Rectal Surg. 2023; Jan 25;36(3):198–200. DOI:10.1055/s-0043-1761153.; McGirt M, Woodworth G, Brooke B, et al. Hyperglycemia independently increases the risk of perioperative stroke, myocardial infarction, and death after carotid endarterectomy. Neurosurgery. 2006; 58: 1066–73. DOI:10.1227/01.NEU.0000215887.59922.36.; Boysen G, Christensen H. Management of hyperglycemia and hypertension in acute stroke. omtecmed. com/CONY/Uploads/assets/abstracts/boysen.pdf; Quinn T, Lees K. Hyperglycaemia in acute stroke — to treat or not to treat. Cerebrovasc Dis. 2009; 27 (1): 148–55. DOI:10.1159/000200453.; Subramaniam B, Panzica P, Novack V, et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective , randomized trial. Anesthesiology. 2009; 110 (5): 970–7. DOI:10.1097/ALN.0b013e3181a1005b.; Carey D, Manas K, Roy, et al. Response to surgical trauma. Surgical emergencies. 1999: 25–36.; Hotamisligil G. Inflammation and metabolic disorders. Nature. 2006; 44: 860–7. DOI:10.1038/nature05485.; Guillou PJ. Adjuvant biological response modifiers after major surgery or trauma. British Journal of Surgery. 1995; 82: 721–23. DOI:10.1002/bjs.1800820602.; Weledji E, Assob J. The systemic response to surgical trauma-a review. East and Central Afr J of Syrgery; 2012. 17(2) 3–13.; Ljungqvist O. Insulin resistance and outcomes in surgery. J Clin Endocrin Metab. 2010; 95: 4217–9. DOI:10.1210/jc.2010-1525.; Brune I, Wilke W, Hensler J, et al. Downregulation of T helper type I immune response and altered pro-inflammatory and anti-inflammatory T cell cytokine balance following conventional but not laparoscopic surgery. Am J Surg. 1999; 177: 55–60. DOI:10.1016/s0002-9610(98)00299-2.; Thorell A, Nygren J, Essen P, et al. The metabolic response to cholecystectomy; insulin resistance after compared with laparoscopic operation. Eur J Surg. 1996; 162: 187–191.; Thorell A, Nygren J, Ljungqvist O. Insulin resistance, a marker of surgical stress. Curr Opin Clin Nutr Metab Care. 1999; 2(1): 69–78. DOI:10.1097/00075197-199901000-00012.; Jehan F, Khan M, Sakran J. Perioperative glycemic control and postoperative complications in patients undergoing emergency general surgery: what is role of plasma hemoglobin A1c? J Trauma Avute Care. 2018; 84 (1): 112–117. DOI:10.1097/TA.0000000000001724.; Sermkasemsin V, Rungreungvanich M, Apinyachon W, et al. Incidence and risk factors of intraoperative hyperglycemia in non-diabetic patients: a prospective observational studysthesiol. 2022 Sep 10;22(1):287. DOI:10.1186/s12871-022-01829-9.; Bardia A, Khabbaz K, Mueller A, et al. The association between preoperative hemoglobin A1c and postoperative glycemic variability on 30-day major adverse outcomes following isolated cardiac valvular surgery. Anesth Analg. 2017; 124 (1): 16–22. DOI:10.1213/ANE.0000000000001715.; Lee S, Nam S, Bae J, et al. Intraoperative hyperglycemia in patients with an elevated preoperative C-reactive protein level may increase the risk of acute kidney injury after cardiac surgery. J Anesth. 2021; Feb;35(1):10–19. DOI:10.1007/s00540-020-02849-w; Maitra S, Kirtania J, Pal S, et al. Intraoperative blood glucose levels in nondiabetic patients undergoing elective major surgery under general anaesthesia receiving different crystalloid solutions for maintenance fluid. Anesth Essays Res. 2013; 7(2): 183–8. DOI:10.4103/0259-1162.118953.; Rahul Kurra Jr, Madhusudhana R. Impact of Different Crystalloids on the Blood Glucose Levels of Nondiabetic Patients Undergoing Major Elective Surgeries. Cureus. 2023 Jan 27;15(1):e34294. DOI:10.7759/cureus.34294.; Nair BG, Horibe M, Neradilek MB. The Effect of Intraoperative Blood Glucose Management on Postoperative Blood Glucose Levels in Noncardiac Surgery Patients. Anesth Analg. 2016; Mar;122(3):893–902. DOI:10.1213/ANE.0000000000001100.; Ljungqvist O, Nygren J, Thorell A. Modulation of post-operative insulin resistance by pre-operative carbohydrate loading. Proc Nutr Soc. 2002; 61 (3): 329–36. DOI:10.1079/PNS2002168.; Kratzing C. Pre-operative nutrition and carbohydrate loading. Proc Nutr Soc. 2011; 70 (3): 311–5. DOI:10.1017/S0029665111000450.; Gustafsson U, Nygren J, Thorell A, et al. Preoperative carbohydrate loading may be used in type 2 diabetes patients. Acta Anaesthesiol Scand. 2008; 52 (7): 946–50. DOI:10.1111/j.1399-6576.2008.01599.x.; Pasechnik IN, Smeshnoy IA, Timashkov DA. Elective surgery and oral carbohydrate loading. Khirurgiia (Mosk). 2020:(6):82–89. DOI:10.17116/hirurgia202006182.; Rajan S, Rahman AA, Kumar L. Preoperative oral carbohydrate loading: Effects on intraoperative blood glucose levels, post-operative nausea and vomiting, and intensive care unit stay. J Anaesthesiol Clin Pharmacol. 2021; Oct-Dec;37(4):622–627. DOI:10.4103/joacp.JOACP_382_19.; Ruzycki SM, Harrison TG, Enns E. Quality gaps in screening and monitoring for postoperative hyperglycemia in a Canadian hospital: a retrospective cohort study. BMJ Open Diabetes Res Care. 2021; Oct;9(1):e002445. DOI:10.1136/bmjdrc-2021-002445.; Zapf M, Patel D, Henson P, et al. PeRiOperative Glucose PRAgMatic (PROGRAM) trial protocol and statistical analysis plan for comparing automated intraoperative reminders to standardise insulin administration in surgical patients at high risk of hyperglycaemia. BMJ Open. 2023; Aug 24;13(8):e072745. DOI:10.1136/bmjopen-2023-072745.; Price CE, Fanelli JE, Aloi JA. Feasibility of intraoperative continuous glucose monitoring: An observational study in general surgery patients». J Clin Anesth. 2023; Aug:87:111090. DOI:10.1016/j.jclinane.2023.111090.; Rajan S, Rahman A, Kumar L. Preoperative oral carbohydrate loading: effects on intraoperative blood glucose levels, post-operative nausea and vomiting, and intensive care unit stay. Journal of anaesthesiology, clinical pharmacology. 2021; 37(4), 622–627. DOI:10.4103/joacp.JOACP_382_19.; Останин П.А., Qeva E., Кривошеева С.В. Определение взаимосвязи между тяжелой интраоперационной гипергликемией и инфекциями в течение 7 дней послеоперационного периода в ортопедической хирургии. Медицинский журнал Астана. 2019; 1(99), 240–244.; https://transmed.almazovcentre.ru/jour/article/view/882
-
20Academic Journal
Συγγραφείς: E. V. Biryukova, М. V. Shinkin, Е. В. Бирюкова, М. В. Шинкин
Πηγή: Meditsinskiy sovet = Medical Council; № 6 (2024); 36-43 ; Медицинский Совет; № 6 (2024); 36-43 ; 2658-5790 ; 2079-701X
Θεματικοί όροι: сахарный диабет 2-го типа, гипергликемия, гликированный гемоглобин, гипогликемии, глюкометры, hyperglycemia, glycated hemoglobin, hypoglycemia, blood glucose meters
Περιγραφή αρχείου: application/pdf
Relation: https://www.med-sovet.pro/jour/article/view/8268/7291; Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health. 2020;10(1):107–111. https://doi.org/10.2991/jegh.k.191028.001.; Liu J, Ren ZH, Qiang H, Wu J, Shen M, Zhang L, Lyu J. Trends in the incidence of diabetes mellitus: results from the Global Burden of Disease Study 2017 and implications for diabetes mellitus prevention. BMC Public Health. 2020;20(1):1415. https://doi.org/10.1186/s12889-020-09502-x.; Wu H, Patterson CC, Zhang X, Ghani RBA, Magliano DJ, Boyko EJ et al. Worldwide estimates of incidence of type 2 diabetes in children and adolescents in 2021. Diabetes Res Clin Pract. 2022;185:109785. https://doi.org/10.1016/j.diabres.2022.109785.; Dabelea D, Rewers A, Stafford JM, Standiford DA, Lawrence JM, Saydah S et al. Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study. Pediatrics. 2014;133(4):e938–45. https://doi.org/10.1542/peds.2013-2795.; Черников АА, Северина АС, Шамхалова МШ, Шестакова МВ. Роль механизмов «метаболической памяти» в развитии и прогрессировании сосудистых осложнений сахарного диабета. Сахарный диабет. 2017;20(2):126–134. https://doi.org/10.14341/7674.; Nathan DM, McGee P, Steffes MW, Lachin JM. Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study. Diabetes. 2014;63(1):282–290. https://doi.org/10.2337/db13-0782.; Xue C, Chen K, Gao Z, Bao T, Dong L, Zhao L et al. Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction. Cell Commun Signal. 2023;21(1):298. https://doi.org/10.1186/s12964-022-01016-w.; Marcovecchio ML. Complications of Acute and Chronic Hyperglycemia. US Endocrinology. 2017;13(1):17–21. https://doi.org/10.17925/USE.2017.13.01.17; Orasanu G, Plutzky J. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol. 2009;53(5 Suppl.):S35–42. https://doi.org/10.1016j.jacc.2008.09.055.; Yamagishi S, Nakamura N, Suematsu M, Kaseda K, Matsui T. Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes. Mol Med. 2015;21(Suppl. 1):S32–40. https://doi.org/10.2119/molmed.2015.00067.; Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137–188. https://doi.org/10.1152/physrev.00045.2011.; Vergès B. Pathophysiology of diabetic dyslipidaemia: where are we? Diabetologia. 2015;58(5):886–899. https://doi.org/10.1007/s00125-015-3525-8.; Pirola L. The DCCT/EDIC study: epigenetic clues after three decades. Diabetes. 2014;63(5):1460–1462. https://doi.org/10.2337/db14-0238.; Liang S, Yin H, Wei C, Xie L, He H, Liu X. Glucose variability for cardiovascular risk factors in type 2 diabetes: a meta-analysis. J Diabetes Metab Disord. 2017;16:45. https://doi.org/10.1186/s40200-017-0323-5.; Wei F, Sun X, Zhao Y, Zhang H, Diao Y, Liu Z. Excessive visit-to-visit glycemic variability independently deteriorates the progression of endothelial and renal dysfunction in patients with type 2 diabetes mellitus. BMC Nephrol. 2016;17(1):67. https://doi.org/10.1186/s12882-016-0300-0.; Rizzo MR, Marfella R, Barbieri M, Boccardi V, Vestini F, Lettieri B et al. Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients. Diabetes Care. 2010;33(10):2169–2174. https://doi.org/10.2337/dc10-0389.; Zinman B, Marso SP, Poulter NR, Emerson SS, Pieber TR, Pratley RE et al. Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2). Diabetologia. 2018;61(1):48–57. https://doi.org/10.1007/s00125-017-4423-z.; Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–412. https://doi.org/10.1136/bmj.321.7258.405.; Ambrosi P, Daumas A, Villani P, Giorgi R. Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to Placebo. Cardiology. 2020;145(6):370–374. https://doi.org/10.1159/000506004.; Khunti K, Ceriello A, Cos X, De Block C. Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: A meta-analysis. Diabetes Res Clin Pract. 2018;137:137–148. https://doi.org/10.1016/j.diabres.2017.12.004.; Дедов ИИ, Шестакова МВ, Майоров АЮ (ред.). Алгоритмы специализированной медицинской помощи больным сахарным диабетом. 11-й выпуск. М.; 2023. Режим доступа: https://www.endocrincentr.ru/sites/default/files/specialists/science/clinic-recomendations/2023_alg_sum.pdf.; Chrvala CA, Sherr D, Lipman RD. Diabetes self-management education for adults with type 2 diabetes mellitus: A systematic review of the effect on glycemic control. Patient Educ Couns. 2016;99(6):926–943. https://doi.org/10.1016/j.pec.2015.11.003.; Selvin E. Hemoglobin A1c-Using Epidemiology to Guide Medical Practice: Kelly West Award Lecture 2020. Diabetes Care. 2021;44(10):2197–2204. https://doi.org/10.2337/dci21-0035.; Gallagher EJ, Le Roith D, Bloomgarden Z. Review of hemoglobin A(1c) in the management of diabetes. J Diabetes. 2009;1(1):9–17. https://doi.org/10.1111/j.1753-0407.2009.00009.x.; McGeoch G, Derry S, Moore RA. Self-monitoring of blood glucose in type-2 diabetes: what is the evidence? Diabetes Metab Res Rev. 2007;23(6):423–440. https://doi.org/10.1002/dmrr.749.; Майоров АЮ, Мельникова ОГ, Филиппов ЮИ. Вопросы самоконтроля гликемии в практике лечения сахарного диабета. Справочник поликлинического врача. 2012;(12):32–36. Режим доступа: https://www.elibrary.ru/tanxdb.; Schnell O, Hanefeld M, Monnier L. Self-monitoring of blood glucose: a prerequisite for diabetes management in outcome trials. J Diabetes Sci Technol. 2014;8(3):609–614. https://doi.org/10.1177/1932296814528134.; Benjamin EM. Self-Monitoring of Blood Glucose: The Basics. Clin Diabetes. 2002;20(1):45–47. https://doi.org/10.2337/diaclin.20.1.45.; ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D et al. 7. Diabetes Technology: Standards of Care in Diabetes-2023. Diabetes Care. 2023;46(Suppl. 1):S111–S127. https://doi.org/10.2337/dc23-S007.; Rao PV, Makkar BM, Kumar A, Das AK, Singh AK, Mithal A et al. RSSDI consensus on self-monitoring of blood glucose in types 1 and 2 diabetes mellitus in India. Int J Diabetes Dev Ctries. 2018;38:260–279. https://doi.org/10.1007/s13410-018-0677-3.; Clar C, Barnard K, Cummins E, Royle P, Waugh N. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess. 2010;14(12):1–140. https://doi.org/10.3310/hta14120.; Durán A, Martín P, Runkle I, Pérez N, Abad R, Fernández M et al. Benefits of self-monitoring blood glucose in the management of new-onset Type 2 diabetes mellitus: the St Carlos Study, a prospective randomized clinicbased interventional study with parallel groups. J Diabetes. 2010;2(3):203–211. https://doi.org/10.1111/j.1753-0407.2010.00081.x.; Polonsky WH, Fisher L, Schikman CH, Hinnen DA, Parkin CG, Jelsovsky Z et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care. 2011;34(2):262–267. https://doi.org/10.2337/dc10-1732.; Poolsup N, Suksomboon N, Rattanasookchit S. Meta-analysis of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients: an update. Diabetes Technol Ther. 2009;11(12):775–784. https://doi.org/10.1089/dia.2009.0091.; Sia HK, Kor CT, Tu ST, Liao PY, Wang JY. Self-monitoring of blood glucose in association with glycemic control in newly diagnosed non-insulin-treated diabetes patients: a retrospective cohort study. Sci Rep. 2021;11(1):1176. https://doi.org/10.1038/s41598-021-81024-x.; Hou YY, Li W, Qiu JB, Wang XH. Efficacy of blood glucose self-monitoring on glycemic control in patients with non-insulin-treated type 2 diabetes: a meta-analysis. Int J Nurs Sci. 2014;1(2):191–195. https://doi.org/10.1016/j.ijnss.2014.05.003.; Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36(5):1384–1395. https://doi.org/10.2337/dc12-2480.; Willis WD, Diago-Cabezudo JI, Madec-Hily A, Aslam A. Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey. Expert Rev Pharmacoecon Outcomes Res. 2013;13(1):123–130. https://doi.org/10.1586/erp.12.80.; Ahmad I, Zelnick LR, Batacchi Z, Robinson N, Dighe A, Manski-Nankervis JE et al. Hypoglycemia in People with Type 2 Diabetes and CKD. Clin J Am Soc Nephrol. 2019;14(6):844–853. https://doi.org/10.2215/CJN.11650918.; Qi Y, Feng W. Cause analysis and nursing countermeasures of self-monitoring of blood glucose in diabetic patients. Electronic J Pract Clin Nurs. 2017;16:44–45. https://doi.org/10.3969/j.issn.2096-2479.2017.16.034.; Моргунов ЛЮ. Гипогликемия и возможности пероральной терапии сахарного диабета типа 2 при хронической болезни почек. Эндокринология: новости, мнения, обучение. 2018;7(4):23–31. https://doi.org/10.24411/2304-9529-2018-14003.; Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2006;49(8):1711–1721. https://doi.org/10.1007/s00125-006-0316-2.; Clarke SF, Foster JR. A history of blood glucose meters and their role in self-monitoring of diabetes mellitus. Br J Biomed Sci. 2012;69(2):83–93. Available at: https://pubmed.ncbi.nlm.nih.gov/22872934.; Evans JM, Mackison D, Emslie-Smith A, Lawton J. Self-monitoring of blood glucose in Type 2 diabetes: cross-sectional analyses in 1993, 1999 and 2009. Diabet Med. 2012;29(6):792–795. https://doi.org/10.1111/j.1464-5491.2011.03567.x.; Freckmann G, Jendrike N, Baumstark A, Pleus S, Liebing C, Haug C. User Performance Evaluation of Four Blood Glucose Monitoring Systems Applying ISO 15197:2013 Accuracy Criteria and Calculation of Insulin Dosing Errors. Diabetes Ther. 2018;9(2):683–697. https://doi.org/10.1007/s13300-018-0392-6.; Pleus S, Freckmann G, Schauer S, Heinemann L, Ziegler R, Ji L et al. SelfMonitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes Mellitus. Diabetes Ther. 2022;13(5):829–846. https://doi.org/10.1007/s13300-022-01254-8.; Jimenez G, Lum E, Huang Z, Theng YL. Reminders for medication adherence in Type 2 diabetes management apps. J Pharm Pract Res. 2020;50(1):78–81. https://doi.org/10.1002/jppr.1595.; Parkin CG, Davidson JA. Value of self-monitoring blood glucose pattern analysis in improving diabetes outcomes. J Diabetes Sci Technol. 2009;3(3):500–508. https://doi.org/10.1177/193229680900300314.